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Abstract
Treatment of large bone defects represents a great
challenge in orthopedic and craniomaxillofacial
surgery. Although there are several methods for bone
reconstruction, they all have specific indications and
limitations. The concept of using barrier membranes
for restoration of bone defects has been developed in
an effort to simplify their treatment by offering a
sinlge-staged procedure. Research on this field of
bone regeneration is ongoing, with evidence being
mainly attained from preclinical studies. The purpose
of this review is to summarize the current
experimental and clinical evidence on the use of
barrier membranes for restoration of bone defects in
maxillofacial and orthopedic surgery. Although there
are a few promising preliminary human studies,
before clinical applications can be recommended,
future research should aim to establish the ‘ideal’
barrier membrane and delineate the need for
additional bone grafting materials aiming to ‘mimic’
or even accelerate the normal process of bone
formation. Reproducible results and long-term
observations with barrier membranes in animal
studies, and particularly in large animal models, are
required as well as well-designed clinical studies to
evaluate their safety, efficacy and cost-effectiveness.
Keywords: bone regeneration, bone defect, barrier
membranes, non-resorbable membranes, bioresorb-
able/absorbable membranes
Introduction
Treatment of large bone defects represents a great chal-
lenge, as bone regeneration is required in large quantity
and may be beyond the potential for self-healing. Large
bone defects include segmental or large cortical defects
created by trauma, infection, tumor resection, aseptic
loosening around implants and skeletal abnormalities
[1,2]. Critical size defect (CSD) is defined as the defect
with the minimum length that cannot be spontaneously
bridged leading to non-union [2,3]. Such defects are gen-
erally accepted to be ≥ 1.5 to 2 times the diameter of the
long bone diaphysis, but they vary according to the host
and the bone [2].
Although many methods for bone reconstruction exist,
they all have specific indications and limitations. Estab-
lished methods are distraction osteogenesis and bone
transport, or bone grafting, including autologous bone
grafts, bone marrow aspirate, allografts, bone substitutes
or growth factors [4-8]. Furthermore, the concept of an
induced-membrane represents another strategy for bone
regeneration and particularly in cases of large bone
defects secondary to trauma, infection or tumor excision.
This method involves a two-stage procedure, where a
‘biological’ membrane is induced as a foreign body
response after application of a cement spacer at the first
stage, acting as a ‘chamber’ for the insertion of autolo-
gous bone-graft at the second stage [9-11]. It has been
shown that this induced membrane possesses osteoin-
ductive, osteogenic and angiogenic properties and several
clinical studies have demonstrated satisfactory results
[9,12]. Finally, the concept of Guided Bone Regeneration
(GBR) using a bioabsorbable or non-resorbable mem-
brane that acts as a barrier to prevent soft-tissue invasion
into the defect and forms a ‘chamber’ to ‘guide’ the bone
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Historically, the concept of GBR has been used in
experimental reconstructive surgery since the mid-1950s,
for spinal fusion [16] and maxillofacial reconstruction
[17,18]. The initial hypothesis was that different cellular
components in the tissue have varying rates of migration
into a wound area during healing and that a mechanical
hindrance would exclude the invasion of inhibiting sub-
stances, such as fibroblasts [19]. Preliminary studies
showed that the use of a non-resorbable membrane as a
mechanical barrier resulted in complete healing of the
bone defect in vivo [20], and collagen membranes pre-
vented the apical migration of epithelium and supported
new connective tissue attachment and tissue regeneration
[21]. The regeneration process occurring within the bar-
rier membrane involves angiogenesis and migration of
osteogenic cells from the periphery towards the center to
create a well-vascularized granulation tissue. Initial orga-
nization of the blood clot is followed by vascular
ingrowth and woven bone deposition, subsequent lamel-
lar bone formation and finally remodeling, resembling
bone growth [22,23]. When ingrowth of bone marrow
into the bone defect was hindered or delayed, regenera-
tion of mineralized bone was also delayed [24]. However,
in large defects, bone formation occurs only to the mar-
ginal stable zone with a central zone of disorganized
loose connective tissue, and, therefore, additional use of
bone-graft materials is required in these cases, with the
graft acting as a scaffold for osteoconduction and as a
source of osteogenic and osteoinductive substances for
lamellar bone formation [23].
Types of barrier membranes, their basic characteristics
and specific considerations
Although different non-resorbable and bioresorbable bar-
rier membranes have been developed and their use has
been extensively investigated, research is ongoing to
develop the ‘ideal’ membrane for clinical applications.
The basic characteristics of these membranes are bio-
compatibility, cell-occlusiveness, space-making, tissue
integration, and clinical manageability [15,25].
Non-resorbable membranes and especially expanded-
polytetrafuoroethylene (e-PTFE, Teflon) have been
extensively studied [26]. They are biocompatible and
maintain their structural integrity during implantation.
They have superior space-maintaining properties and
capacity for cell occlusion than degradable membranes,
as the latter tend to collapse depending on the size of the
defect [27]. Other non-resorbable membranes are tita-
nium reinforced ePTFE, high-density-PTFE, or titanium
mesh mainly used in oral and maxillofacial surgery [23]
(Table 1). Semipermeable ePTFE is more effective than
the high-density ePTFE with respect to bone regenera-
tion [28]. For bone regeneration of large segmental bone
defects, the cylindrical titanium mesh cage has been used
as a scaffold with satisfactory preliminary results [29].
However, a second surgical procedure is required for
removal, which represents a limitation and involves a
potential risk to the newly regenerated tissues [30].
Finally, membrane exposure is frequent, increasing the
risk of secondary infection [31,32].
Bioresorbable membranes have been developed to
avoid the need for surgical removal. Such membranes
have been extensively studied, mainly in animals but also
in humans in maxillofacial, regenerative periodontal, and
neuro-surgery [14,33-38]. Recently, commercially avail-
able bioresorbable membranes have also been used for
reconstruction of long bone defects in the clinical setting.
It has been shown that they enhance bone healing, espe-
cially in cases with bone defects > 4 to 5 cm or with sig-
nificant associated soft-tissue loss, where autologous
bone grafting alone is not recommended due to risk of
resorption [39], and they also secure the grafting material
[31]. There are two broad categories of bioresorbable
membranes: the natural and the synthetic membranes.
Natural membranes are made of collagen or chitosan,
whereas synthetic products are made of aliphatic polye-
sters, primarily poly(L-lactide) (PLLA) and poly(L-lac-
tide-co-glycolide) (PLGA) co-polymers [23]. Overall,
their advantages are: 1) they allow for a single-step proce-
dure, 2) the shape and volume of the regenerated bone
can be predefined-prefabricated, 3) they are radiolucent
allowing imaging, and 4) their bioresorption eliminates
potential effects of stress shielding of the regenerated
bone. Conversely, there is variability and lack of control
over the rate of membrane resorption, which is influ-
enced by factors such as the local pH and material
composition. A summary of the main characteristics,
advantages and disadvantages of the different bioresorb-
able membranes is presented in Table 1 [13,21,31,
38,40-59]. Currently, mainly PLLA membranes are avail-
able for clinical use in orthopedic surgery; whereas
PLLA, collagen and ePTFE membranes are used for GBR
in maxillofacial, dental and neuro- surgery.
Although a number of barrier membranes are already
being used in clinical practice, novel membranes have
been developed in an effort to overcome the limitations
of the currently used membranes. Such novel mem-
branes include alginate membranes, new degradable co-
polymers, hybrid or nanofibrous membranes, as well as
amniotic membranes. They are summarized in Table 1
[60-75]. Ongoing research is evaluating these novel
membranes, aiming to establish an ‘ideal’ membrane for
bone regeneration with optimized characteristics in
terms of biocompatibility, space-making, tissue integra-
tion and clinical manageability for maximum clinical
efficacy and safety.
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Table 1 Summary of the different types of barrier-membranes used for reconstruction of bone defects
Types of membranes




(different subtypes, predominantly type-I collagen,
derived from different animals, (bovine or porcine)
and from different sites (tendon or dermis) [40]
- highly biocompatible (no adverse effect to surrounding
tissues during degradation)
- it promotes wound healing [41]
- it allows good integration with connective tissue (fibrous
encapsulation with differentiation of a periosteum-like tissue
upon the external bony surface) [42,43]
- osteoblasts and fibroblasts can attach to collagen
membranes irrespective of its origin [44]
- differently cross-linked collagen membranes can promote
cell attachment and proliferation [45]
- degradation in vivo is too rapid to maintain the structural integrity
necessary for bone regeneration [44]
- different cross-linking techniques used to prolong degradation
time (it varies from four weeks up to six months) [40,41,46]
- differently cross-linked collagen membranes can also inhibit cell
attachment and proliferation [45]
- chemicals used for cross-linking have cytotoxic effects on the
surrounding tissues leading to gap formation between the
membrane and the connective tissue and facilitate microbial
accumulation [43] (to address this, a non-chemical cross-linking
nanofibrous collagen membrane has been developed) [47]
- variable mechanical properties among the different available
membranes
- risk of peri-operative rupture
- moistening of the membrane (unavoidable in vivo) alters
considerably the mechanical properties [48]
- possible disease transmission from animals to humans [21,31]
Chitosan or chitosan-collagen hybrid - non-toxic natural polymer (polysaccharide)
- it enhances wound healing and bone formation [49]
- it has hemostatic properties [50]
- excellent biocompatibility [51], osteogenic cells can
proliferate and express osteogenic markers [51]
- chitosan-hybrid membranes have superior mechanical
properties [52,53]
- limited evidence from in vivo studies
Synthetic
membranes
Aliphatic polyesters: PLLA, PLGA, polydioxanone
and their co-polymers [52-54]
- the most commonly used and studied bioabsorbable
polymer
- commercially available and approved for clinical use
- by changing the composition and the manufacturing
procedure, resorption time, handling properties and
mechanical durability can be adjusted to suit the clinical
situation [54]
- different chemical compositions did not affect on bone
regeneration in vivo [55]
- slow-degrading membranes induce greater amounts of
neovascularization and a thinner fibrous capsule versus fast
degrading membranes [56]
- they can induce host-tissue response and foreign body reactions
during degradation (by non-enzymatic hydrolysis) [13,38,42,57-59]




And others: titanium reinforced ePTFE, high-density-PTFE, or
titanium mesh [23]
- extensively studied [26]
- biocompatible
- they maintain their structural integrity during implantation
and have superior space-maintaining properties and capacity
for cell occlusion than degradable membranes
- semipermeable ePTFE is more effective than the high-
density ePTFE [28]
- for large segmental bone defects, cylindrical titanium mesh
cage used as a scaffold [29]
- a second surgical procedure is required for removal (additional
potential risk to the newly regenerated tissues [30])
- membrane exposure is frequent, increasing the risk of secondary
infection [31,32]





















Table 1 Summary of the different types of barrier-membranes used for reconstruction of bone defects (Continued)
Novel membranes
Alginate membrane - close assimilation to bone surface
- no inflammatory response [60]
- easy handling with an alginate base self-setting barrier
membrane versus a ready-made membrane [61]
-more efficacious versus collagen membranes for mandibular
and tibial defects [62,63]
- limited evidence from in vivo studies
Others [64-68]:
- degradable biopolymer poly (lactide-co-ε-caprolactone)(PLCL),
- a nano-hydroxyapatite/polyamide(nHA/PA66) composite
- an in situ-formed polyethylene-glycol-hydrogel membrane
- amniotic membranes
- a bacterially-derived polymer
- a hybrid membrane consisting of layers of collagen containing
hydroxyapatite (HA) and chitosan [69]
- polyethersulfone (PES) electrospun nanofibrous membranes
[70]
- a biomimetic tubular calcium phosphate (CaP)-coated
nanofiber mesh combined with platelet rich plasma-mediated
delivery of BMP-7 [71]
- Latex [72]
- membranes with additional anti-bacterial properties or
antimicrobial coating [73-75]
- optimized properties for GBR
- improved three-dimensional structure and osteogenic
bioactivity
- they can be loaded with cells to mimic natural bone
- no foreign body inflammatory reaction or rejection and
satisfactory bone formation
- membranes with additional anti-bacterial properties or
antimicrobial coating may reduce membrane-associated
infections




















The role of porosity and topography of the barrier
membranes
The pore size of the barrier membrane is very important
in order to prevent excessive penetration of fibrous tis-
sue into the bone defect (soft tissue ingrowth) but to
allow neovascularization and bone formation. Differ-
ences in the intensity of bone regeneration were
observed depending on the pore size [76]. Pores in
excess of 100 μm are required for the rapid penetration
of highly vascular connective tissue, and small pores
tend to become filled with more avascular tissue [77], as
they are inadequate for penetration of capillaries [78]. A
pore size of 50 to 100 μm allows bone ingrowth, but
size greater than 150 μm is required for osteon forma-
tion [79,80]. A recent animal study showed that macro-
porous membranes facilitated greater bone regeneration
compared to microporous membranes and prevented
significant soft-tissue ingrowth [81]. Further research
should be directed to identify the critical pore size, since
an increase in pore size may result in decreased
mechanical properties. A multilayer scaffold has been
suggested to achieve suitable mechanical properties and
porosity and mimic the structure of cancellous and cor-
tical bone [82]. In addition to the porosity, the tri-
dimensional topography of the membrane with inter-
connecting pores and channels is also important, as it
can alter the cell occlusion properties and the biologic
response of different cell types to the membrane [83].
The role of soft tissue ingrowth
Although barrier membranes are used to prevent soft-tis-
sue invasion, a thin layer of soft-tissue ingrowth (up to 1
mm thickness) can be formed under the membrane, over-
lying the regenerated bone [84-86]. This may be secondary
to shrinkage of the initial blood clot under the membrane,
entrapment of air or membrane micromovements. Cur-
rently, it is not known if this soft-tissue layer under the
membrane undergoes mineralization if left for a long per-
iod. Some studies reported this tissue-layer was a perios-
teum-like tissue, and others reported it to be fibrous tissue
[81] but its clinical implications are unknown.
The role of mechanical stability
It is known that micromovements between bone and
any implanted material prevent bone formation, result-
ing in the development of fibrous tissue [87,88]. Ade-
quate stability and minimal stress are required to allow
the early tissue that infiltrates through the pores to dif-
ferentiate into bone by direct or appositional bone for-
mation [81]. Bone formation can occur within porous
materials even with limited initial movement provided
the site is highly vascular and local inflammatory reac-
tion is minimal [89]. New vascular network formation,
which is a prerequisite for bone formation, is also highly
sensitive to mechanical conditions with delayed mechan-
ical loading significantly enhancing bone formation and
stimulating vascular remodelling by increasing the num-
ber of large vessels and decreasing the number of small
vessels [90]. Therefore, optimal stability should be pro-
vided in terms of the attachment of the membrane itself,
since most bioresorbable membranes are flexible and
they cannot be applied without additional fixation as
well as the type of fixation of the bone defect [91]. To
maximize stability of the membrane, the use of mem-
brane-fixing pins has been suggested. It has been
observed that bone formation is significantly enhanced
when the resorbable membrane is tightly attached and
immobilized to the bone surface [92]. Regarding the
effect of the type of additional fixation to the process of
bone formation, it is known that intermediate tissues,
such as fibrous tissue, cartilage and woven bone, pre-
cede final bone formation, with the mechanical loading
affecting the regeneration process and different stress
distribution favoring or inhibiting differentiation of par-
ticular tissue phenotypes [93]. High shear strain and
fluid flows stimulate fibrous tissue formation, whereas
lower levels stimulate formation of cartilage, and even
lower levels favor ossification. It has been demonstrated
in vivo that there is more rapid and more organized
new bone formation in rigidly fixed defects with plate
osteosynthesis, covered with a resorbable collagen mem-
brane, compared to non-rigidly fixed defects [94].
Literature Review
As research on the field of bone regeneration is ongoing
and the evidence is expanding, we aimed to summarize
the current experimental and clinical research on the
use of barrier membranes for restoration of bone defects
and focus on maxillofacial and orthopedic applications.
We searched the PubMed Medline and Ovid Medline
databases, from 1991 to 2011, to retrieve all relevant
articles reporting on the use of absorbable and/or non-
absorbable membranes for bone regeneration in animal
and clinical studies. Different combinations of searching
terms were used including: membrane/bone regenera-
tion/long bone/bone defect/segmental bone defect/seg-
mental mandibular defect/mandibular defect. The search
was restricted to studies published in English. We ana-
lyzed all preclinical studies using established animal
models to evaluate barrier membranes for bone regen-
eration of segmental, large and critical-sized mandibular
or long-bone defects, in which bone regeneration was
documented and assessed using radiological or biome-
chanical and/or histological analysis. Regarding the clini-
cal studies, all papers reporting on the clinical use of
barrier membranes were analyzed.
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The majority of studies were preclinical and the clini-
cal studies were mainly retrospective case series. The
summaries of the studies are shown in Tables 2 to 7.
Animal studies
Tables 2 to 5 summarize the preclinical studies with non-
absorbable or bioabsorbable membranes. There were 23
animal studies reporting on the use of membranes in
maxillo-facial surgery for reconstruction of segmental or
critical mandibular defects using small or large animal
models (Table 2, 15 studies [31,34,54,63,64,94-103] and
Table 3, 8 studies [22,104-110], respectively). Overall, the
membrane-treated groups showed improved bone forma-
tion within the mandibular defects compared to the non-
treated animals [22,96,98]. Differences in the rate of bone
regeneration and the inflammatory response in the sur-
rounding soft tissues were observed with different types
of membranes [31,97,100].
A total of 27 animal studies reported on the use of
membranes for reconstruction of long bone defects. There
were 21 studies using a small animal model (Table 4)
[55,60,62,76,82,111-126], and only six studies using a large
animal model (Table 5) [127-132]. As in maxillofacial ani-
mal studies, superior bone healing has also been observed
in long bones treated with a barrier-membrane compared
to the non-treated defects using bioabsorbable as well as
non-resorbable membranes [111,117,118,121]. Bone
defects treated with improved bilayer membranes dis-
played better regeneration of cortical bone tissue [112],
whereas novel composite membranes displayed affluent
neovascularization and bone formation with little fibrous
tissue formation [82]. The differences in chemical compo-
sition of the polylactide membranes did not seem to have
an evident effect on bone healing in a small animal model
[55], but different pore sizes resulted in differences in the
intensity of the bone regeneration process [76]. Large ani-
mal studies also showed promising results for restoration
of long bone defects but only when combined with addi-
tional bone grafting material [131,132]. When two con-
centric perforated membranes (the tube-in-tube implant)
were used in combination with cancellous bone graft in
segmental diaphyseal defects, a ‘neocortex’ was reconsti-
tuted with well-defined thickness [132].
Clinical studies
Tables 6 and 7 summarize the clinical studies, in which
absorbable membranes were used for bone regeneration
of the mandible and the long bones, respectively. The
absorbable membranes used were either experimental
materials [57,133], similar to the ones used in the animal
studies, or commercially available material manufactured
for other purposes [13,134].
There are only three studies in humans where bioab-
sorbable membranes have been used for reconstruction
of segmental or large mandibular bone defects using
bioresorbable PLLA barrier membrane (mesh) in combi-
nation with autologous bone graft (Table 6) [33,57,133].
The majority of the bone defects were secondary to
benign or malignant tumors of the mandible, but other
causes included infection, alveolar atrophy and trauma.
Overall, the preliminary clinical results were satisfactory
(rated as excellent and good in 56.5% and 27.4%, res-
pectively). Radiologically, a certain degree of bone
absorption was noted in more than half of the cases;
nevertheless, only in one case was the absorption signifi-
cant (up to 30%).
Finally, regarding the use of bioabsorbable membranes
in long bone defects, there are only two clinical studies
reporting on the clinical results in a total of 16 patients
(Table 7) [13,134]. Long bone defects were mainly post-
traumatic, but there were also a few cases of osteomyeli-
tis and benign tumor resection. The bioresorbable PLLA
synthetic membrane used was used in combination with
autologous cancellous bone graft or bone marrow, and
long bone fixation. Preliminary results showed healing of
the defects and satisfactory function in all cases, except
one which required further intervention.
Discussion
Barrier membranes are among the most widely studied
scaffolds for tissue regeneration, including bone, and the
choice of type of membrane depends largely on the
required duration of membrane function [23]. Regarding
bone regeneration, their use is mainly indicated for bone
regeneration in sites where limited mechanical loading
exists, such as in cranial, oral and maxillofacial applica-
tions. Even though there is extensive research on barrier
membranes in animals, human studies are still few.
Therefore, the most reliable current evidence originates
mainly from studies in animals of higher phylogenetic
scale which are still limited in number. Findings from the
experimental setting indicate that GBR follows the same
course of steps regardless of the animal. Bone quality
though is highly dependent on the species (evolution
hierarchy), bone healing potential (age, general nutri-
tional status), the membrane used, local conditions (vas-
cularity, embryological origin of bone) and load-sharing
pattern of the fixation method; and, therefore, the results
and the potential clinical use should be interpreted with
caution [2,13,33,76,123,130].
Long bone versus maxillofacial bone defects
According to the preliminary clinical reports, the time
period for complete regeneration of bone in the mandible
is three months, whereas long bones require more than
two times the same period (seven months) [33,57]. This
is most likely to be attributed to the greater vascularity of
the mandible and the surrounding soft tissues as well as
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platelet-rich plasma (PRP) gel alone or
human fascia lata membrane (HFL)
Group I: HFL
Group II: PRP gel
Group III: HFL+PRP
Histological at 12 weeks None of the control sides and the PRP
treated sides had full development of bone
or filling of the defect through bone
bridging.
The application of PRP gel alone or in







a novel nanofibrous membrane of a
degradable biopolymer poly (lactide-
co-ε-caprolactone) (PLCL)
A 5 mm critical-sized defect Histological at four weeks The assessment of cell compatibility showed
favorable cell adhesion and growth on the
nanofiber PLCL membrane. At four weeks, the
PLCL nanofibrous membrane induced better
guided new bone formation than the defect
control group while protecting the bone










Defects covered with a membrane (PDLLCL,
collagen, or expanded ePTFE) or left
uncovered (control).
At 2, 4 and 12 weeks using
transversal microradiography
For defect closure and bone thickness all
membrane-treated groups showed effect
modification between time and membrane;
these effects were more significant and larger
in the collagen and ePTFE groups. In the
non-treated controls no effect modification
was observed. The membrane groups
showed significantly better results than the
control groups. The ePTFE and collagen
membranes performed equally well and
better than the PDLLCL membrane during
this experiment. PDLLCL membrane not







a novel degradable synthetic
membrane (Vivosorb) of poly(dl-
lactide-epsilon-caprolactone) (PDLLCL)
versus collagen and ePTFE
membranes
A standardized 5 mm circular mandibular
defect
Four groups (control/uncovered, PDLLCL,
collagen, ePTFE).
At 2, 4, and 12 weeks
Microradiography and muCT
Bone formation was progressive when the
defect was covered with a membrane. More
bone formation was observed underneath
the collagen and ePTFE membranes than the
PDLLCL membranes.
Bone formation in PDLLCL-covered defects
was less and the high variation in the PDLLCL
samples at 12 weeks may be caused by the
moderate adherence of this membrane to






a novel calcium alginate film (CAF)
versus conventional collagen
membrane (CM)
Bilateral critical size 5 mm mandibular defects
covered with CAF (experimental group) or
conventional collagen membrane (CM) or left
empty (control group)
At one, two, four, six and eight
weeks. Morphological and
histomorphometric evaluation
The CAF guided early bone growth and
appeared more effective as a bioabsorbable
GTR membrane than CM.
A significantly greater percentage of newly
generated bone in CAF defects than that in
CM defects and empty defects from two to
six weeks post-operation.
At six and eight weeks, significantly more




























- HFL (human fascia lata)
- HP (human pericardium)
- HFT (human fascia temporalis)
- BP (bovine pericardium),
- e- PTFE
9-mm circular mandibular defects were
created bilaterally.
Five groups for each membrane and the
defect on the other side served as a control.
Histological at ten weeks Membranes were significantly superior to the
controls.
HFL, HP, BP, and PTFE were significantly
superior to HFT
HFT is not recommended for GBR techniques







ester carbonate) (PDTE carbonate)
membrane (thickness 0.2-0.3 mm)
A through-and-through defect (12 × 6 mm).
Group 1: defects left unfilled but covered
with membrane
Group 2: defects filled with bioactive glass
mesh and covered with membrane
Controls were left uncovered and unfilled.
Histological at 6, 12, 24 and 52
weeks
PDTE carbonate elicited a modest foreign
body reaction in the tissues, which was
uniform throughout the study. New bone
formation was seen in all samples after six
weeks. Group 1 had more new bone
formation until 24 weeks and after this the
difference settled. PDTE carbonate
membranes have good biocompatibility and
are sufficient to enhance bone growth






calcium alginate film (CAF) with CM Circular bone defects with 5-mm diameter
one side were covered with a CAF, and the




image pattern analysis system at
one, two, four, six, and eight weeks
CM absorbed more slowly but collected
fewer osteoinductive factors (P < .05) in the
early period. CAF induced dense bone
formation, whereas CM produced less newly
formed bone.
CAF is more efficacious than CM in guided






collagen membrane Bilateral critical size (4 mm) defects maxillary
segments were rigidly or not rigidly fixed
using bone microplates and screws or
osteosynthetic wires. The defects were
covered with a resorbable collagen
membrane or left uncovered.
At four weeks
serial radiographs and histologic/
histomorphometric analyses
The rigidly fixed defects, covered with
membrane, showed the most rapid and
organized new bone formation. They
averaged approximately 40% more new bone
in the osteotomy site compared with the
rigidly fixed defects with no membrane. No
rigidly fixed defects with no membrane








type I bovine collagen membrane
(DPPA)
5 mm diameter full-thickness circular bone
defects
one side covered by the membrane
the other side uncovered (control)
Histological at 7, 15, 30, 90, and 180
days
Although at early stages of healing similar
amounts of bone formation were observed in
the both groups, after one month of healing,
most of the experimental defects were
completely closed with new bone, while in
the control defects, only limited amounts of
new bone were observed at the rims and in
the lingual aspect of the lesions. In the 90-
and 180-day animals, all experimental defects
were completely closed, while in the control
defects, no statistically significant increase in




























Circular transosseous ‘critical size’ defects in
mandibles of rats were either implanted with
recombinant human bone morphogenetic
protein type 2 (rhBMP-2) or were left empty;
half the number of implanted and half the
number of empty defects were covered with
the e-PTFE membrane
At 12 and 24 days of healing by a
histomorphological scoring system
Implantation of rhBMP-2 alone resulted in
bony bridging of the defect after only 12
days, but also in voluminous amounts of new
bone outside the original defect area. When
rhBMP-2 was combined with membrane,
newly formed woven bone bridged the
defect and the bone contour was maintained
by the membrane. The combined treatment
with membrane and rhBMP-2 demonstrated
a significantly better bone healing than with
e-PTFE membrane alone at both 12 days and
24 days of healing. RhBMP-2 had a strong
osteoinductive potential and this potential
was retained when combining the rhBMP-2
with the osteopromotive membrane
technique, yielding better bone healing than
with the membrane alone, and at the same






ten different biodegradable and non-
biodegradable membrane materials
Standardized bilateral critical size mandibular
defects and randomly covered with the
different types of membrane
Scanning electron microscopy and
histological analysis at six weeks
At six weeks, varying degrees of bone healing
seen beneath the different membranes. Some
of the membranes revealed a good
osteopromotive effect, whereas others had
little or no beneficial effects on bone healing,
even if seemingly chemically closely related.
Certain membrane materials caused a
pronounced inflammatory response in the
surrounding soft tissue, while others






e-PTFE membrane Standardized through-and-through critical
size defects (non-union)
On one side of the jaw, the defect was
covered both buccally and lingually with an
expanded polytetrafluoroethylene (e-PTFE)
membrane.
On the other side no membrane was used.
Histological at six weeks Complete healing with bone of the
membrane-covered defects at six weeks. No
cartilage was present in any of the
specimens. At the control sites (no
membrane), the amount of newly produced
bone showed variations, most through
defects revealing the presence of a remaining








A 2 × 3 mm defect
the contralateral side: no membrane
Histological analysis from 15 days to
6 months
The histological analysis demonstrated
increasing bone fill in the test specimens
from 15 to 180 days, whereas only 35% to
40% of the defect area in the control sides
was filled with bone after 3 to 6 months.
Ingrowth of muscular, glandular and
connective tissue was consistently occurring






three types of bioabsorbable
membranes (BAMs) of polylactic/
polyglycolic acid copolymers with
different absorption times and
comparisons with e-PTFE membrane.
Standardized 5 mm critical size defects Histological at 1 to 12 weeks BAMs were well tolerated by the tissue,
causing just a mild inflammatory reaction
along the membrane surfaces as long as the
material remained in the tissue. The BAMs
were as efficient as e-PTFE membranes.
Healing in conjunction with one type of BAM
seemed to occur somewhat more rapidly.
BAMs represent a valid alternative to e-PTFE
membranes to improve bone regeneration.


































collagen Segmental defects after mandibulectomy using
calcium phosphate ceramics and collagen
membrane with a delayed bone marrow grafting






Successful osseous colonization bridged the entire
length of the defects. The good new bone
formation at the center and the periosteum-like
formation at the periphery suggest the
osteoinductive role of the bone marrow graft and






acellular dermal matrix (ADM) in
comparison with a bioabsorbable
synthetic membrane
Control group (bioabsorbable membrane made
of glycolide and lactide copolymer)
Test group (ADM as a membrane).
At 8 and 16 weeks,
radiological evaluation
At 16 weeks: Clinical
measurements of the width
and thickness of the
keratinized tissue and
histomorphometric analysis
ADM acted as a barrier in GBR, with clinical,
radiographic and histomorphometric results similar







poly L/DL-lactide 80/20% membrane
with different permeability patterns
10 mm segmental defects
Mechanical stabilization and 6 treatment groups:
control, BG alone (bone graft), microporous
membrane (poly L/DL-lactide 80/20%) (Mi); Mi
plus BG; microporous laser-perforated (15 cm2
ratio) membrane (Mip), and Mip plus BG.
Histological,
histomorphometry and
fluorescence microscopy at six
months
BG protected by Mip was consistently related to
larger amounts of bone versus other groups. No
difference between defects treated with Mip alone
and BG alone. Mi alone rendered the least bone
area and reduced the amount of grafted bone to
control levels. Bone formation was incipient in the
BG group at three months regardless of whether
or not it was covered by membrane. In contrast,
GBR with Mip tended to enhance bone formation
activity at three months.
The use of Mip alone could be a useful alternative
to BG. The combination of Mip membrane and BG
efficiently delivered increased bone amounts in









collagen membrane versus cross-
linked collagen membrane (CCM).
three standardized defects filled with bone chips
and deproteinized bovine bone mineral (DBBM),
and covered by three different methods: control
= no membrane; test 1 = collagen membrane;
and test 2 = cross-linked collagen membrane
(CCM). Each side of the mandible was allocated
to one of two healing periods (8 or 16 weeks).
At 8 and 16 weeks
Histomorphometric analysis
For all groups, the defect fill height increased
between weeks 8 and 16. The CCM group showed
a statistically significant increase over time and the
highest value of all treatment modalities after 16
weeks of healing. The CCM showed a limited
beneficial effect on bone regeneration in
membrane-protected defects in dog mandibles
when healing was uneventful. However, the
increased complication rate with CCM requires a






type I collagen membrane (GLYM)
using a novel cross-linking
technology versus a non-cross-linked
bilayer type I and III collagen
membrane (BCM)
Mandibular bilateral critical size defects
five groups: GLYM + bovine bone mineral (BBM),
BCM + BBM, BBM alone, sham-operated, or GLYM
alone.




Membrane-protected sites displayed bone filling
between the BBM particles with almost complete
restoration of the original ridge morphology that
increased with time up to 16 weeks and remained
unchanged at 24 weeks. Both membranes showed
marked degradation within 16 to 24 weeks, with
BCM inconsistency that was undetectable in one
of four sites at 8, 16, and 24 weeks. Membrane
ossification was observed in all GLYM sites and in
only one BCM site, which progressed with time to
24 weeks. Bone increased by approximately 1 mm
on the lingual side, where the GLYM membrane




























Mandibulectomy defects (25 mm × 15 mm)
ePTFE-TR or control (repositioning flaps)
At four to six months
Macroscopic and histological/
histomorphometric evaluation
The size of the residual defect in the experimental
sites was much smaller compared to the controls,
which was statistically significant.
Histomorphometric measurements of new bone
formation revealed a similar pattern. These








reinforced ePTFE membranes Standardized 8 × 19 mm mandibular defects
Reinforced ePTFE membranes held in place with
mini screws and sutures for anywhere from 1 to
12 months. No material added to the defect.
Digital subtraction radiology
and fluorescent labelling with
tetracycline and
histomorphometry
Data suggest that membranes left in situ for 1
month or less result in minimal bone gain
compared with membranes left in place from 2 to
12 months. In addition, labelling and stained
sections clearly showed that the bone produced






standard and prototype reinforced e-
PTFE membranes
Standard and prototype reinforced e-PTFE
membranes and control (no membranes)
At two and four months
Histologic evaluation
Control sites without membranes exhibited
incomplete osseous healing with a persisting
defect. Test sites with membranes demonstrated
significantly better bone healing, although bone
regeneration was not yet completed at 4 months.
Histologic evaluation showed that bone
regeneration, once activated, progresses in a
programmed sequence which closely resembles































Rats tibia decalcified cortical
osseous membrane
[GenDerm(®)]
To study the effect of using lyophilized bovine bone
(GenOx(®) organic matrix) with (or without) GBR
(using a decalcified cortical osseous membrane
[GenDerm(®)])
Surgically created critical-size defects
group I (control)
group II (defect filled with GenOx(®)
group III (defect covered by GenDerm(®)
group IV (defect filled with GenOx(®) and covered
by GenDerm(®)
At 30 or 90 days
Histological and
histomorphometrical
Superior bone healing in all groups compared to
control group.
Group IV showed evidence of more advanced











Three groups: a nanofiber-reinforced bilayer
membrane, a nanofibrous membrane, or a
collagenous membrane alone
At three and six weeks Radiological
and histological
Bilayer membrane group had more bony tissue
formation at thre weeks. At six weeks, only the
bilayer membrane-treated bone defects displayed
better regeneration of cortical bone tissue. Other







collagen A 5 mm in diameter defect created transcutaneously
Group I: control, left to heal spontaneously
Group II (BOC+BG): filled with Bio-Oss Collagen and
Bio Gide Perio membrane
Group III: BOC and platelet-rich plasma
At one and three months
Histological
Greater number of bone trabeculas after








(CAF) versus collagen or
no membrane
Circular bone 5 mm diameter defects
CAF versus collagen versus no membranes




and an image pattern analysis
system
CAF induced dense bone formation, whereas CM












Composite membranes are implanted into a fibular
defect to evaluate the osteoconductivity and the
efficacy as a barrier to fibrous tissue ingrowth:
affluent blood vessels and bone formation found in
the center of the scaffold and little fibrous tissue










Surgical bone defects, five groups:
Group I (control); Group II (Gen-ox: lyophilized
bovine bone organic matrix)
Group III (Gen-ox + Laser);
Group IV (Gen-ox + Gen-derm);
Group V (Gen-ox + Gen-derm + Laser)
At 15, 21, and 30 days.
Histological assessment.
Improved amount of collagen fibers at early stages
of the bone healing (15 days) and increased amount
of well organized bone trabeculae at 30 days on














1 cm segmental radial defect
(2.5 times the radial bone diameter)
Radiological
Every two weeks for an eight-week
period.





Four rabbits at two week intervals
EC group: an increase in the new bone density was
apparent in all quadrants during the first four weeks,
followed by a sharp decline in bone density.
CH group: different biological behavior, lesser
increment in bone density in the first four weeks
but continued throughout the eight weeks.
Possible cause: degradation of membrane products
and foreign body reaction.
Based on histological findings: EC membranes are
better osteoinducers.





























submucosa (SIS) used as
preformed tubular SIS
grafts
Critical length segmental defects
four groups: unfilled or filled with morselized
cancellous bone, or spanned with intramedullary
tubes or periosteal sleeves fabricated from SIS
Radiological (biweekly)
At 12 weeks histological, and
mechanical testing
New bone formation in all defects treated with
cancellous bone. Fibrous tissue and no bone
formation in defects left unfilled or treated with SIS
SIS persisted at twelve weeks.
Cellular response to SIS: mild mononuclear infiltrate
in the loose or delaminated superficial layers of the
tubes and sleeves, with few cells in the deeper
layers.
The ability of SIS to support or stimulate growth of










Segmental defect, four groups:
I: untreated + plaster,
II: plate fixation
III: membrane + plate fixation
IV: sponge + plate fixation
Radiological
At eight weeks histological
Group I + II: no healing
Group III: healing




Rat tibia alginate membrane
(bioabsorbable)
Calcium chloride aqueous solution dropped into the
bone defect, which is filled with sodium alginate
aqueous solution.
n/a Evaluation of short-term biocompatibility of alginate
membrane. The healing process in bone defects
covered with an alginate membrane was delayed in
comparison with that of controls; however, the
defect was restored to nearly original condition.
In contrast, in the controls, bone defect repairs
exhibited partitioning as a result of connective tissue
involvement.
A relation between the sodium alginate
concentration and the rate of absorption of the
sodium alginate membrane was noted.








control groups (without membrane)
Histological
At six, eight, or ten days using
immunohistochemistry and
confocal laser scanning microscopy
to investigate new bone
mineralization
The bone occupation ratio increased day by day,
but the experimental groups had significantly higher
ratios than control groups (without membrane) at
each of the time periods. More rapid mineralization
in the experimental groups vrsus controls.
GBR accelerates the migration of osteogenic cells,
the formation of new bone, and mineralization in








10 mm diaphyseal defects
(both sides: test and control)
Test side: bone marrow ingrowth into the defects
was hindered or delayed (plugging the opening of
the cut bone ends with gutta-percha points;
plugging with Gelfoam; or by removing the bone
marrow by flushing with saline), in all defects: an
ePTFE membrane, shaped as a tube
Regular radiological
At four to five months, histological
Any attempts to delay or prevent bone marrow











Ten hydroxyapatite-coated titanium fixtures inserted




Tensile shear-stress at break testing
and histological
Lower performance without membrane
Neoformed cortical bone present cervically around































10 mm diaphyseal segmental defects
- membranes from poly(L/D-lactide)
- poly(L/DL-lactide)
to determine whether chemical composition of the
membrane affected the bone healing in the defect.
Control: previous study with same animal model and
similar defects not covered with membranes or
covered with poly(L-lactide) membranes
Radiological at two, four, six, and
eight weeks
Histological at 3, 6 and 12 months
At one year: complete bone regeneration in the
defects covered with the poly(L/D-lactide)
membrane, only one animal with no regeneration
and one animal with pseudarthrosis.
Complete bone regeneration in all animals for the
poly(L/DL-lactide) membrane (one animal died
during surgery).
The quality of the interface between the new bone
and the membrane seemed to be affected by the
chemical structure of the polylactides used for
membranes preparation. The differences in chemical
composition of the polylactide membranes did not
have an evident effect on the bone regeneration




Rats tibia alginate membrane 3 mm × 10 mm bicortical bone defect filled with
0.5, 1.0, or 1.5% Na-Alg aqueous solution, then 3%
calcium chloride aqueous solution was dropped on
the Na-Alg solution to form an alginate membrane.
four groups: (a) control group (no solutions)
(b) alginate membrane with 0.5% Na-Alg solution
(c) alginate membrane with 1.0% Na-Alg solution
(d) alginate membrane with 1.5% Na-Alg solution
Histological
At four weeks
Control group: bone defect filled with connective
tissue.
0.5% Na-Alg solution: part of the alginate membrane
had disappeared and connective tissue had begun
to grow in the bone defect.
1.0 or 1.5% Na-Alg solution: the alginate membrane
prevented any ingress of connective tissue to the
bone defect, and the bone defect was reconstructed
with new bone. At this stage, the alginate
membrane still was observed, and the amount of
unabsorbed alginate was larger for higher
concentrations of Na-Alg aqueous solution. No









The defect was either left unfilled or implanted with
SIS, demineralized cortical bone (DMCB), or
ovalbumin.
Radiographically and histologically
after 3, 6, 12, and 24 weeks.
Tissue remodelling within the defect was evident by
week three in SIS- and DMCB-treated rats. Filling was
characterized initially by infiltration of mononuclear
cells and extracellular material in SIS-implanted rats
and multifocal remodelling bone particles and
cartilage formation in DMCB-implanted rats.
Cartilage was observed as early as three weeks and
bone as early as six weeks in SIS-implanted rats.
Filling of the defect arose from multiple foci in
DMCB-implanted rats, but was contiguous with and
parallel to the ulnar shaft in SIS-implanted rats,
suggesting that defect repair by SIS may be
conductive rather than inductive. Rats in which the
defect was left unfilled demonstrated slow but
progressive filling of the defect, characterized by
mononuclear cell infiltrates and fibrous extracellular































2.5 to 3 cm mid-diaphyseal defect





Ulna left intact and no adjunctive internal or external
fixation
Radiological (biweekly)
At 12 weeks, histologic and
microradiographic evaluation
The bone defects covered with membranes were
completely reconstituted by six to eight weeks.
Untreated defects healed with less bone formation
and in a more disorganized pattern. Histologic
evaluation of the implants demonstrated that the
entire lumen of the implant was filled with bone,
with some periosteal bone formation occurring on
the outer surface of the membrane. Direct
apposition of bone onto the membrane surface or
minimal fibrous tissue interposition between
membrane and new bone. No foreign body or






silicone membrane 10-mm defect on radius silicone membrane sutured
as a tube
10-mm defects were also produced on the control
sides.
At 12 weeks radiological, three-
point bending test, and histological
By the 12th week, seven of ten experimental sides
were healed, two were healed with a connective
cartilage zone, and one was not healed. None of the











pore size (10 to 20
microns), and large pore
size (20 to 200 microns)
(bioabsorbable)
10 mm diaphyseal defect
No internal fixation (assumption that the intact ulna
splints the radius adequately)
Radiological at two and four weeks
and six months
Bone regeneration in the majority of cases,
regardless of pore size.
Some differences in the intensity of the bone
regeneration process. At two weeks, bone formation
seen in all animals, but at six months five rabbits of
five, four rabbits of five, and three rabbits of five
implanted respectively with microporous, medium
pore-size and large pore-size membrane showed








7 to 10 mm segmental diaphyseal defects
Study group: membrane formed as a tube
Control: contralateral side with no membrane
Radiological (obtained repeatedly)
and histological at 13 or 27 weeks
Control group: some early subperiosteal callus
formation and non-union of the defects at six
weeks.
Study group: subperiosteal bone formation at the
bone ends first observed at two weeks. At nine
weeks, a thin cortical bone bridged the defect along
the inner surface of the membrane.
Histology: an interrupted line of thin, cortical bone
was observed along the inner surface of the barrier
membrane. Fatty bone marrow occupied the central









1 cm segmental, osteoperiosteal defects





Membrane-treated defects: all healed by forming
callus external to the membrane fusing the bone
fragments. Loose connective tissue was



































Hyaluronan (Hyalonect) Periosteal reconstruction of bone
defects filled with a variety of
conventional bone filling
compounds.
Histological at six weeks Hyalonect was shown to allow the
regeneration of bone within the
humeral defects while preventing
fibrotic tissue in-growth, and allowing
regeneration of tissue which, by six












(length: a quarter of the full
length of humerus, width: a
quarter of middle diameter of
the lateral aspect of humerus)
Control group: the contralateral
humerus
Computed tomography
(CT) at four and eight
weeks and histological
The result suggested that TCP/PLGC
membrane is a good guided bone
regeneration material to restore the











Segmental bone defect Histological at six weeks The scaffold protects the bone defect
site as revealed by new bone formation
within the margins of the defect and
adjacent to the scaffold has been
shown.
Minimal to no soft tissue invasion into
the defect site. Dermal membrane
material may be used as a scaffold for
periosteum regeneration by allowing
for cellular repopulation,












membranes +ABG or a
vascularized periosteal flap.




weekly until week 16.
Polymeric membranes of adequate
composition and pore size combined
with ABG or vascularized periosteum















Single or double-tube designs
+/_ cancellous bone grafting
Radiological (X-rays and
CT) and histological at
16 weeks.
In groups without bone grafting non-
union developed and persisted until 16
weeks. Defect healing was only
observed when ABG was used along
with the single or double microporous-
perforated membranes. (new bone







poly(LDL-lactide) 4 cm diaphyseal segmental
defects
1) a single microporous
membrane
2) a microporous internal
membrane, and a membrane on
the outer surface of the cortex
(external membrane)
3) an external membrane laser-
perforated (800 to 900
micrometers openings)
4) ABG and a single perforated
membrane
5) one perforated internal
membrane into the medullary
cavity and another membrane
on the outer surface of the
cortex




No bone healing in Groups 1, 2, 3, and
5. Only in Groups 4 and 6 the defects
healed. In Group 4, new bone was
dispersed across the ‘medullary canal’
formed by the membrane. In Group 6,
the new bone had grown into the
space between the outer and inner
membranes, forming the ‘neocortex’.
The resorbable polymeric implant
consisting of two concentric perforated
membranes (the tube-in-tube implant)
used in combination with cancellous
bone graft to treat segmental
diaphyseal defects allows for the
reconstitution of the ‘neocortex’ with
well-defined thickness.
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_ malignant (22) and benign (30) tumors, cysts
















Poor (not effective) 16.1%
X-ray of the regenerated bone:
0 to 10% bone resorption in 31
cases
10% to 20% in six cases







41 Segmental defect or large
partial defects
mandibulectomy
_ malignant (19) and benign (22) tumors - Excellent: 19/41 (46.3%)
Good 13/41 (31.7%)
Poor 9/41 (22.2%) (local
infection)
86.5% Success rate










































































≤ 6 cm Benign tumor,
Osteomyelitis and
trauma
polymeric scaffolds (sponges, 450 to 700 μm
pore size) impregnated with bone marrow
Not
reported
X-rays Presence of bone
regeneration and satisfactory
function




















to the different mechanical environment and less stress-
shielding of the fixation method used. Furthermore, it
may also be explained by the different pathways of bone
formation during the regeneration process due to the dif-
ferent embryological origin of the mandible (intramembra-
nous ossification) compared to long bones (endochondral
ossification) [135]. Considering these differences, the
‘ideal’ barrier membrane may be different for maxillofacial
and orthopedic applications. For example, in the case of
long bone defects, the ‘ideal’ membrane may require
improved mechanical properties, a prolonged degradation
period in the case of an absorbable membrane, and even
different membrane porosity to allow vascular ingrowth
from the surrounding soft tissues to optimize bone forma-
tion within the defect.
Is current evidence adequate enough for use in humans?
Despite the fact that experimental evidence is well estab-
lished and preliminary results from clinical studies are
encouraging, there are still several points which prevent
the safe and wide use of bioabsorbable membranes in
humans. Healing potential in humans is different from
that of animals and it occurs with various speeds in differ-
ent bones (for example, mandible versus tibia), mainly due
to the difference in vascularity and/or embryological ori-
gin. Therefore, the size of the segmental defect, able to be
bridged using membranes, is not yet defined in humans
[132]. Additionally, the load-bearing of different bones
varies widely. Even if the bone gap may be successfully
bridged by the regenerated bone, more evidence is
required regarding the time it will be structurally mature
to cover the functional requirements. Since load-bearing is
vital for the formation and progression of bone formation,
the load sharing capacity of the fixation method is of
utmost importance. There is no information yet on how
the new bone will develop and mature in various types of
fixation methods, that is, which may be considered the
optimal fixation for bone regeneration in humans.
Other major parameters affecting the efficacy of bone
regeneration are the characteristics of the membranes,
such as composition, thickness, porosity, and perforation
size [13,132]. These variables are yet to be defined in
humans, because they may act in conjunction with the
healing potential of each bone and may be used to opti-
mize bone regeneration in bones with low healing poten-
tial or with a deficient local environment.
Specific considerations for orthopedic surgery
Bioresorbable membranes are currently being used
mainly for bone regeneration in oral and maxillofacial
surgery in humans. However, their use in various ortho-
pedic conditions also represents a field of interest, espe-
cially since the number of revision surgeries [136,137]
and limb salvage procedures is increasing [138,139]. For
example, such membranes can be shaped as tubular
chambers, thus preserving the continuity of the diaphysis
for the repair of large diaphyseal bone defects [140]. By
forming a ‘tube-in-tube implant’ using two concentric
perforated membranes in combination with cancellous
bone-graft, the reconstitution of the ‘neocortex’ with
well-defined thickness was possible for the treatment of
segmental diaphyseal defects in sheep tibiae [132]. Barrier
membranes can also help to prevent significant absorp-
tion of the bone graft which is estimated to be up to 40%
to 50% at four weeks [132] and seems to be due to
absorption of bone that is not mechanically functioning
[141]. As these membranes are radiolucent, they allow
assessment of bone formation with conventional radio-
graphs, CT or MRI [13], which is important for monitor-
ing the regeneration process.
The evidence on the efficacy for cortical perforation
(decortication) during GBR procedures in an effort to
enhance bone formation remains controversial [142].
Studies have shown that cortical perforations increase
the blood supply, facilitate angiogenesis, and allow access
for progenitor cells from the bone marrow into the
‘chamber’ [142] whereas other studies showed that bone
formation occurred from a non-injured cortical bone sur-
face and that perforations were not required as they did
not increase bone formation [59,81]. However, since
there are no relevant human clinical studies and the rele-
vant animal studies refer to mandibular defects, where
local vascularity is superior to long bones, recommenda-
tions for additional bone decortication cannot be made
for orthopedic GBR applications [142].
Finally, barrier membranes can be used in combination
with bone grafting to augment osseointegration of ortho-
pedic implants in the case of bone defects [143]. They
may also be used for regeneration of other tissues with
potential orthopedic applications, including tendon
regeneration in rotator cuff repair, and post-traumatic
nerve regeneration [144,145], as the preliminary results
are encouraging.
Enhancement of bone regeneration and future research
Biological augmentation of GBR with growth factors
The interest in accelerating bone formation has led
researchers to combine the membrane technique with
osteoinductive or growth factors. Although the concept of
additional biological enhancement of bone formation
using growth factors that enhance proliferation, chemo-
taxis, and differentiation of osteogenic cells seems promis-
ing, results are often controversial. In a study evaluating
the long-term outcome of oral implants placed in bone
augmented with an allograft and a collagen membrane
with or without the addition of recombinant-human bone
morphogenetic protein-2 (rhBMP-2), no statistically signif-
icant differences were observed regarding the clinical and
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radiological outcomes [146]. On the contrary, numerous
in vivo and in vitro studies have demonstrated improved
bone formation when barrier membranes are loaded with
platelet-derived growth factor (PDGF-BB) [147], basic
fibroblast growth factor (FGF2) [148], and rhBMP-2
[99,146,149].
Controversial evidence may be secondary to insuffi-
ciency in maintaining therapeutic concentrations of
growth factors within bone defects due to rapid clearance
and use of different delivery methods with supraphysiolo-
gical non-standarized doses to obtain therapeutic efficacy
[147]. Furthermore, current research usually evaluates
one or a combination of two growth factors, which does
not reflect the complex physiological process of bone for-
mation. Research is ongoing to develop novel membranes
and scaffolds with improved growth factor delivery sys-
tems to accelerate bone regeneration of critically-sized
segmental bone defects with promising preliminary
results [150]. Moreover, with a controlled spatiotemporal
delivery of growth factors, adequate local protein concen-
trations can be improved and maintained for optimal
regenerative efficacy, avoiding the currently used supra-
physiologic doses and the concomitant adverse effects
[151]. Finally, the optimal ‘combination’ of growth factors
to be delivered has also to be established.
Other strategies to improve bone regeneration
Aiming to maximize or accelerate bone formation, sup-
plementary strategies have been investigated in combi-
nation with barrier membranes and grafting. The
potential use of low-level laser therapy (LLLT) has been
evaluated as an adjunct for the regeneration of long
bone defects in animal studies with positive results
[114,152]. Supplementary treatment with hyperbaric
oxygen has also shown synergistic regenerative effects in
the past [153]. Additionally, preliminary results have
shown that systemic administration of synthetic salmon
calcitonin accelerated bone regeneration of the defects
[154].
Research is ongoing to evaluate other methods to
enhance bone regeneration, such as local administration
of parathyroid hormone (PTH(1-34)) [155] and other
growth factors [156] with promising preliminary results.
Moreover, methods to optimize surface microtopogra-
phy of the membranes have also been investigated to
enhance bone formation at the cellular and molecular
level [157]. Finally, in the future, improved barrier mem-
branes can be used as part of the bone-tissue engineer-
ing approach combined with osteoprogenitor cells and/
or osteopromotive factors or even gene therapy, aiming
to produce improved composite grafts [1]. Preliminary
research is promising. For example, a novel three-
dimensional porous polymer poly(ε-caprolactone) (PCL)
scaffold coated with adeno-associated virus encoding
BMP2 using both ex vivo or in vivo gene therapy, led to
increased bone ingrowth with increased mechanical
properties in a rat femoral defect model [158].
Conclusions
The concept of barrier membranes for restoration of
large bone defects has been developed in an effort to
simplify their treatment by offering a sinlge-staged pro-
cedure and to overcome the limitations of current bone
regeneration strategies. Research in this field is ongoing,
with evidence being mainly gained from preclinical stu-
dies. Preliminary human studies have also shown pro-
mising results in maxillofacial, oral and orthopedic
surgery. Nevertheless, before clinical applications can be
recommended, future research should aim to generate
and establish the ‘ideal’ barrier membrane. The addi-
tional use of bone-grafting materials within the mem-
brane to fill the defect should also be evaluated, aiming
to ‘mimic’ or even accelerate the normal process of
bone formation. Finally, reproducible results and long-
term observations with certified barrier membranes in
animal models are required, and especially in large ani-
mal long bone defect models, as well as well-designed
clinical studies to evaluate their safety, efficacy and cost-
effectiveness.
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